Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr-Jun;44(2):145-146.
doi: 10.1590/2175-8239-JBN-2022-E004.

Use of rituximab in glomerulopathies

[Article in English, Portuguese]
Cristiane Bitencourt Dias  1 , Viktoria Woronik  1
Affiliations
Editorial

Use of rituximab in glomerulopathies

[Article in English, Portuguese]
Cristiane Bitencourt Dias et al. J Bras Nefrol. 2022 Apr-Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

Comment on

Similar articles

See all similar articles

References

    1. Gauckler P, Shin JI, Aberici F, Audard V, Bruchfeld A, Busch M, et al. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - what is known and what is still unknown? Autoimmun Rev. 2020 Nov;19(11):102671. - PubMed
    1. Ahmad A, Mitrofanova A, Zeidan YH. Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes. FASEB J. 2017 Feb;31(2):771–80. - PMC - PubMed
    1. Duarte I, Oliveira J, Outerelo C, Godinho I, Pereira M, Fernandes P, et al. Rituximab in glomerular diseases: case series and narrative review. Braz J Nephrol. 2021 Dec; doi: 10.1590/2175-8239-JBN-2021-0120. Epub ahead of print. - DOI - PMC - PubMed
    1. Browna LC, Jobsona MA, Schoberb FP, Changb EH, Falka RJ, Nachmana PH, et al. The evolving role of rituximab in adult minimal change glomerulopathy. Am J Nephrol. 2017;45(4):365–72. - PMC - PubMed
    1. Kidney Disease Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int Suppl. 2021 Oct;100(4S):1–150. - PubMed